在COVID-19疫苗专利活动的全球格局
Eduardo Mercadante1, Timo Minssen2, Kenneth C Shadlen3
1Postdoctoral Research Associate, Centre for Commercial Law Studies, Queen Mary University of London, 67-69 Lincoln's Inn Fields, London WC2A 3JB, United Kingdom.
Vaccine
|October 20, 2025
概括
针对COVID-19疫苗的全球专利申请揭示了独特的开发和合作模式. 非G7 G20国家在申请和新型疫苗平台方面处于领先地位,并观察到企业和大学伙伴关系的增加.
科学领域:
- 生物技术是生物技术.
- 知识产权法 知识产权法 知识产权法
- 疫苗学 疫苗学 疫苗学
背景情况:
- 对COVID-19疫苗的全球专利申请进行了分析,以了解开发起源和寻求保护的模式.
- 这项研究建立在2023年世界知识产权组织 (WIPO) 报告的基础上,检查了8个疫苗平台的1178个专利家族.
研究的目的:
- 确定COVID-19疫苗开发和专利申请的地理分布.
- 调查企业申请人,个人发明人,大学和研究组织 (URO) 之间的合作模式.
- 将COVID-19疫苗专利活动与更广泛的制药和生物技术专利趋势进行比较.
主要方法:
- 分析了8个平台类别的1178个COVID-19疫苗专利家族.
- 使用关于申请国和申请人类型 (企业,个人,URO) 的WIPO数据.
- 在126个司法管辖区搜索申请,分为G7,非G7,G20和非G20国家.
主要成果:
- 非G7 G20国家是申请最常见的目的地,并产生了最多的专利家族,包括新的平台.
- 在G7和非G20国家的申请中,企业申请者占据主导地位,而在非G7和非G20国家的申请中,URO同样重要.
- UROs专注于传统平台,而企业申请者优先考虑新型平台;COVID-19疫苗专利显示出更频繁的合作,特别是在公司和UROs之间.
结论:
- 与更广泛的制药专利相比,COVID-19疫苗专利表现出明显的地理和协作特征.
- 企业实体和学术机构之间加强合作是COVID-19疫苗创新的关键特征.
- 了解这些模式可以了解全球疫苗研发动态.
相关概念视频
01:51Vaccinations
51.2K
Overview
51.2K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
230
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
230
01:29Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:13Bioequivalence studies: Biowaivers
220
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
220